BIOMAT Database Logo BIOMAT Database Logo

Immune reconstitution inflammatory syndrome following treatment of cutaneous tuberculosis with rifampin, isoniazid, pyrazinamide, and ethambutol. 2024

Ralina Karagenova, and Bao Xin Liang, and David J Elpern, and Dylan E Lee, and Casey M Phan, and Douglas W Johnson
John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii.

UI MeSH Term Description Entries

Related Publications

Ralina Karagenova, and Bao Xin Liang, and David J Elpern, and Dylan E Lee, and Casey M Phan, and Douglas W Johnson
Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
November 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Ralina Karagenova, and Bao Xin Liang, and David J Elpern, and Dylan E Lee, and Casey M Phan, and Douglas W Johnson
Antituberculous agents. Isoniazid, rifampin, streptomycin, ethambutol, and pyrazinamide.
April 1983, Mayo Clinic proceedings,
Ralina Karagenova, and Bao Xin Liang, and David J Elpern, and Dylan E Lee, and Casey M Phan, and Douglas W Johnson
Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients.
April 2006, Antimicrobial agents and chemotherapy,
Ralina Karagenova, and Bao Xin Liang, and David J Elpern, and Dylan E Lee, and Casey M Phan, and Douglas W Johnson
The effect of hemodialysis on isoniazid, rifampin, pyrazinamide, and ethambutol.
May 1999, American journal of respiratory and critical care medicine,
Ralina Karagenova, and Bao Xin Liang, and David J Elpern, and Dylan E Lee, and Casey M Phan, and Douglas W Johnson
Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
October 1977, The American review of respiratory disease,
Ralina Karagenova, and Bao Xin Liang, and David J Elpern, and Dylan E Lee, and Casey M Phan, and Douglas W Johnson
Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment.
August 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Ralina Karagenova, and Bao Xin Liang, and David J Elpern, and Dylan E Lee, and Casey M Phan, and Douglas W Johnson
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.
June 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Ralina Karagenova, and Bao Xin Liang, and David J Elpern, and Dylan E Lee, and Casey M Phan, and Douglas W Johnson
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
July 2019, Antimicrobial agents and chemotherapy,
Ralina Karagenova, and Bao Xin Liang, and David J Elpern, and Dylan E Lee, and Casey M Phan, and Douglas W Johnson
Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.
November 2019, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Ralina Karagenova, and Bao Xin Liang, and David J Elpern, and Dylan E Lee, and Casey M Phan, and Douglas W Johnson
[Results of treatment of newly detected pulmonary tuberculosis with rifampin combined with isoniazid and ethambutol].
November 1980, Pneumonologia polska,
Copied contents to your clipboard!